Skip to main content

Systemische Sklerodermie

  • Chapter
Medizinische Therapie 2005|2006
  • 47 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Weiterführende Literatur

  • Clements PJ, Lachenbruch PA, Ng SC et al. (1990) Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 33: 1256–1263

    CAS  PubMed  Google Scholar 

  • Clements PJ, Furst DE, Wong WK et al. (1999) High dose versus low dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two year, double blind, randomized, controlled clinical trial. Arthritis Rheum 42:1194–1203

    CAS  PubMed  Google Scholar 

  • Hoeper MM, Schwarze M, Ehlerding S et al. (2000) Long term treatment of primary pulmonary hypertension with aerolized iloprost, a prostacyclin analogue. N Engl J Med 342: 1866–1870

    Article  CAS  PubMed  Google Scholar 

  • Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M (1994) Clinical and prognostic associations based on serum antinuclear antibodies in japanese patients with systemic sclerosis. Arthritis Rheum 37: 75–83

    CAS  PubMed  Google Scholar 

  • LeRoy EC, Krieg T, Black C et al. (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15: 202–205

    CAS  PubMed  Google Scholar 

  • Lock G, Holstege A, Lang B, Schölmerich J (1997) Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 92: 763–771

    CAS  PubMed  Google Scholar 

  • Steen VD, Constantino JP, Shapiro AP, Medsger TA (1990) Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Int Med 113: 352–357

    CAS  PubMed  Google Scholar 

  • Steen VD, Medsger TA (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41: 1613–1619

    CAS  PubMed  Google Scholar 

  • Tyndall A, Black C, Finke J, Peter H, Gratwohl A (1997) Treatment of systemic sclerosis with autologous hemopoetic stem cell transplantation. Lancet 349: 254–356

    Article  CAS  PubMed  Google Scholar 

  • White B, Moore WC, Wigley FM et al. (2000) Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Int Med 132: 947–954

    CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Heidelberg

About this chapter

Cite this chapter

Hunzelmann, N. (2005). Systemische Sklerodermie. In: Schölmerich, J., et al. Medizinische Therapie 2005|2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27385-9_15

Download citation

  • DOI: https://doi.org/10.1007/3-540-27385-9_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21226-3

  • Online ISBN: 978-3-540-27385-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics